Clough is a $1.00 + stock. It was rated poorly in recent times due to non core issues. Another Orica story in the making.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025